Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05925_nanopub.RAqz89uwS9Wde6z0-cz-Lgv4dBjcLBBP0aYybofx4rTW0#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05925 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05925 label "alprazolam lingual spray [drugbank:DB05925]" assertion.
- drugbank:DB05925 seeAlso DB05925 assertion.
- drugbank:DB05925 description "Alprazolam lingual spray is developed by NovaDel Pharma Inc. which is engaged in the development of novel drug delivery systems for prescription and over-the-counter drugs. NovaDel's vision for an alprazolam lingual spray is one that could be used by patients prone to suffering from anxiety in the face of certain predictable stimuli (e.g., closed-in spaces, airplane flight, public speaking, etc.). Such patients could successfully navigate such settings by dosing just prior to the event or at the moment when they encounter such a situation." assertion.
- drugbank:DB05925 identifier "drugbank:DB05925" assertion.
- drugbank:DB05925 title "alprazolam lingual spray" assertion.
- drugbank:DB05925 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05925 drugbank_vocabulary:drugbank-id "DB05925" assertion.
- drugbank:DB05925 bio2rdf_vocabulary:x-identifiers.org DB05925 assertion.
- drugbank:DB05925 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05925" assertion.
- drugbank:DB05925 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05925 bio2rdf_vocabulary:identifier "DB05925" assertion.